Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP33 inhibits Slit2-Robo1. 2 / 2

| 2

➶

reach

"Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT."

30896071

➶

reach

"Several downstream effectors, including Abl [XREF_BIBR], Dock [XREF_BIBR], Ena (32), ERK1/2 [XREF_BIBR], small Rho GTPases [XREF_BIBR], USP33 [XREF_BIBR] and Vilse [XREF_BIBR], have been reported to mediate the inhibitory effect of Slit2-Robo1 signaling on cell motility, proliferation, apoptosis and angiogenesis in different cell types."

27923383

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...